Ichnos Sciences (United States)

Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial

Bernard Combe, Alan Kivitz, Yoshiya Tanaka et al. · Annals of the Rheumatic Diseases · 2021 · 228 citations · Full text

Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial

René Westhovens, William F. C. Rigby, Désirée van der Heijde et al. · Annals of the Rheumatic Diseases · 2021 · 134 citations · Full text

Randomized, double-blind, placebo-controlled trial of ISC 17536, an oral inhibitor of transient receptor potential ankyrin 1, in patients with painful diabetic peripheral neuropathy: impact of preserved small nerve fiber function

Sunil Jain, Ramanathan Balamurugan, Monika Tandon et al. · Pain · 2021 · 51 citations · Full text

Pain Therapy, Peripheral Nerve Injury, Pain Medicine +25

Phase 2b randomized trial of OX40 inhibitor telazorlimab for moderate-to-severe atopic dermatitis

Barbara Rewerska, Lawrence Sher, Sady Alpizar et al. · Journal of Allergy and Clinical Immunology Global · 2023 · 39 citations · Full text

Asthma, Ox40 Inhibitor Telazorlimab, Allergy +9

Evaluation of the antimicrobial efficacy and skin safety of a novel color additive in combination with chlorine disinfectants

Kevin Tyan, Jason Kang, Katherine Jin et al. · American Journal of Infection Control · 2018 · 23 citations · Full text

Antibiotics, Novel Color Additive, Chlorine Disinfectants +10